The Lymphoma InterVEntion: personalized feedback and a self-management intervention to improve patient reported outcomes

Conditions: lymphoma
self-management
web-based intervention
personalized feedback
education
patient reported outcomes

Registration Number: NL-OMON27749

Lead Sponsor: etherlands Comprehensive Cancer Organisation (IKNL)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Not specified

Target Recruitment: 222

Inclusion Criteria

1. Diagnosed 6 to 12 months before inclusion with Hodgkin lymphoma or non-Hodgkin lymphoma, including chronic lymphocytic leukaemia as defined by the International Classification of diseases for Oncology-3 codes (ICD-O-3)

2. Diagnosed in one of the participating hospitals

Exclusion Criteria

1. Problems with the Dutch language

2. Severe psychopathology or dementia

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Self-management skills (heiQ; Osborne, 2007), Satisfaction with information provision (ISQ; Thomas, 2004) , and psychological distress (HADS; Zigmond, 1983).<br><br /><br /><br>1. Osborne RH, Elsworth GR, Whitfield K. The Health Education Impact Questionnaire (heiQ): an outcomes and evaluation measure for patient education and self-management interventions for people with chronic conditions. Patient education and counseling. 2007;66(2):192-201.<br /><br>2. Thomas R, Kaminski E, Stanton E, Williams M. Measuring information strategies in oncology - developing an information satisfaction questionnaire. Eur J Cancer Care. 2004;13(1):65-70.<br /><br>3. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta psychiatrica Scandinavica. 1983;67(6):361-70.<br>

Secondary Outcome Measures

Name	Time	Method
1. General health-related quality of life (EORTC QLQ-C30)<br /><br>2. Disease-specific health-related quality of life (EORTC QLQ-HL27 for Hodgkin lymphoma, QLQ-NHL-HG29 for aggressive and QLQ-NHL-LG20 for indolent non-Hodgkin lymphomas, and QLQ-CLL17 for chronic lymphocytic leukaemia <br /><br>3. Adjustment to cancer (MAC)<br /><br>4. Self-effecacy (SE-28)<br /><br>5. Illness perceptions (B-IPQ)<br /><br>6. Fatigue (MFI) <br /><br>7. Health care use<br /><br><br /><br>Medical disease-specific data are collected form the Netherlands Cancer Registry and for the experimental groups, technical data on the use of personalized feedback and the web-based intervention are collected, in addition to the standardized questionnaires.